Skip to main content
  • English
  • Español
Oryzon
  • Company
    • Overview
    • Strategy
    • Team
  • Epigenetics
    • Epigenetics
    • LSD1
  • Programs
    • Pipeline
    • Iadademstat
    • Vafidemstat
    • Collaborations
    • Publications
  • Patients
    • Clinical Trials
  • Investors
    • Share Information
      • Share Performance
      • Shares and Capital Structure
      • Dividends
      • Share Issues
      • Takeover Bids
      • Shareholdings
    • Financial Information
      • Financial Results and Accounts
      • Public Periodic Information
      • Average supplier payment period
    • CNMV Filings
    • Analyst Coverage
    • Corporate Governance
      • General Shareholders Meeting
      • Board of Directors
      • Board Committees
      • Shareholder Agreements
      • Annual Corporate Governance Reports
      • Annual Director Remuneration Reports
    • Corporate Social Responsibility
  • News & Events
    • Press releases
    • Events
  • Contact
    • Contact
    • Email Alerts
    • Join us

Breadcrumb

  1. Home
22-23 April 2024

Swiss Biotech Day 2024

Markthalle

Basel

Switzerland

16-17 April 2024

Van Lanschot Kempen Life Sciences Conference

Amsterdam

Netherlands

10 April 2024

Investing in Oncology Forum 2024

IVA Konferenscenter

Stockholm

Sweden

5 April 2024

ORYZON to provide corporate progress updates at several events in April

4 April 2024

ORYZON receives the INNOVATIVE SME seal from the Spanish Ministry of Science and Innovation

26 February 2024

ORYZON reports financial results and corporate update for quarter ended December 31, 2023

18-20 March 2024

BIO-Europe Spring 2024

CCIB

Barcelona

Spain

28-29 February 2024

17th Annual European Life Sciences CEO Forum

Hilton Zurich Airport Hotel

Zurich

Switzerland

14-15 February 2024

Bio-Neuroscience

Rosarium

Amsterdam

Netherlands

4-7 February 2024

Keystone Symposia Epigenetic Mechanisms and Cancer Treatment

Eldorado Hotel & Spa, Santa Fe

NM

United States

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Current page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Next page Next ›
  • Last page Last »
Subscribe to
Logo Oryzon
  • Company
    • Overview
    • Strategy
    • Team
  • Epigenetics
    • Epigenetics
    • LSD1
  • Programs
    • Pipeline
    • Iadademstat
    • Vafidemstat
    • Collaborations
    • Publications
  • Patients
    • Clinical Trials
  • Investors
    • Share Information
    • Financial Information
    • CNMV Filings
    • Analyst Coverage
    • Corporate Governance
    • Corporate Social Responsibility
  • News & Events
    • Press releases
    • Events
  • Contact
    • Contact
    • Email Alerts
    • Join us
  • © Oryzon Genomics, S.A. - All Rights Reserved

    • Legal
    • Privacy Policy
    • Cookie Policy
    • Ethics Channel